Demo Sign up Log In

Immunitybio Inc (IBRX)

Cash Conversion Ratio

0.30×

Quarterly · Period ending: Jun 30, 2026

IBRX Cash Conversion Ratio

Latest reported0.30×period endingJun 30, 2026

Latest reported0.30×period endingJun 30, 2026

IBRX Quarterly Cash Conversion Ratio (0.04× → 0.30×)

Latest values, visible window

High-resolution chart · PNG

IBRX cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	0.304×
Mar 31, 2026	0.1219×
Dec 31, 2025	1.1567×
Sep 30, 2025	1.0361×
Jun 30, 2025	0.8733×
Mar 31, 2025	0.6713×
Dec 31, 2024	1.4748×
Sep 30, 2024	1.1846×
Jun 30, 2024	0.7511×
Mar 31, 2024	0.8071×
Dec 31, 2023	0.528×
Sep 30, 2023	0.9738×
Jun 30, 2023	0.6404×
Mar 31, 2023	0.7971×
Dec 31, 2022	1.0133×
Sep 30, 2022	0.8702×
Jun 30, 2022	1.1333×
Mar 31, 2022	0.9947×
Dec 31, 2021	0.899×
Sep 30, 2021	0.9215×
Jun 30, 2021	0.8794×
Mar 31, 2021	0.8485×
Dec 31, 2020	1.771×
Sep 30, 2020	0.595×
Jun 30, 2020	0.8949×
Mar 31, 2020	0.8484×
Dec 31, 2019	0.6987×
Sep 30, 2019	1.0898×
Jun 30, 2019	1.0677×
Mar 31, 2019	0.8489×
Dec 31, 2018	0.9272×
Sep 30, 2018	0.8984×
Jun 30, 2018	0.6764×
Mar 31, 2018	0.7418×
Dec 31, 2017	1.0239×
Sep 30, 2017	0.8699×
Jun 30, 2017	0.9852×
Mar 31, 2017	0.5942×
Dec 31, 2016	0.4997×
Sep 30, 2016	0.4315×
Jun 30, 2016	0.2752×
Mar 31, 2016	0.3238×
Dec 31, 2015	0.1549×
Sep 30, 2015	0.1137×
Jun 30, 2015	0.04×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.